{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:19:26Z","timestamp":1791839966173,"version":"4.3.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The increasing use of technological devices for the management of diabetes is related to the prolonged exposure of patients\u2019 skin to chemical and mechanical agents and, consequently, to the increased risk of developing dermatological complications. Among these, contact dermatitis is the most insidious skin disorder. Despite the magnitude of the issue, no universally accepted recommendations on the management of this common complication are currently available. Our observational study aimed to describe all the solutions adopted by patients and their caregivers to treat and prevent the appearance of contact dermatitis and to describe the clinical impact of this cutaneous complication. Twenty-one pediatric patients (mean age 12.1 \u00b1 3.7 years) with type 1 diabetes were recruited in the study. The most common treatment used to treat acute skin lesions was the application of topical corticosteroids, sometimes associated with topical antibiotics (9.5%). In order to prevent the further appearance of dermatitis, the most frequently adopted measure was the use of hydrocolloid and\/or silicone-based adhesives, followed by the application of protective barrier films. One patient reported benefit from the off-label use of fluticasone propionate nasal spray. However, only 52.4% of the study participants achieved a definitive resolution of the skin issue, and 38.1% of patients were forced to discontinue insulin pump therapy and\/or continuous glucose monitoring. No differences were observed in glycated hemoglobin values between the period before and after the onset of contact dermatitis. Our study confirms the severity of this dermatological complication that may hinder the spread of new technologies for the management of diabetes. Finally, our findings highlight the importance of establishing close collaboration both with pediatric allergy specialists to prescribe the most suitable treatment and with manufacturing companies to ensure that adhesives of technological devices are free of harmful well-known sensitizers.<\/jats:p>","DOI":"10.3389\/fendo.2022.846137","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T09:31:31Z","timestamp":1647336691000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Technologies for Type 1 Diabetes and Contact Dermatitis: Therapeutic Tools and Clinical Outcomes in a Cohort of Pediatric Patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Stefano","family":"Passanisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Salzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Galletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Aramnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Caminiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"Pajno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S007","article-title":"7. Diabetes Technology: Standards of Medical Care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6940","article-title":"Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial","volume":"323","author":"Laffel","year":"2020","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0304","article-title":"Continuous Glucose Monitoring Improves Glycemic Outcomes in Children With Type 1 Diabetes: Real-World Data From a Population-Based Clinic","volume":"44","author":"Sanderson","year":"2021","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0142","article-title":"Benefits and Barriers of Continuous Glucose Monitoring in Young Children With Type 1 Diabetes","volume":"21","author":"Hilliard","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.608232","article-title":"Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections in Pediatric Type 1 Diabetes: A Meta-Analysis and Prospective Cohort Study","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-019-0665-4","article-title":"Type 1 Diabetes Mellitus Management in Young Children: Implementation of Current Technologies","volume":"87","author":"Nevo-Shenker","year":"2020","journal-title":"Pediatr Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/1179551420959077","article-title":"Quality of Life in Children With Diabetes Treated With Insulin Pump Compared With Multiple Daily Injections in Tertiary Care Center","volume":"13","author":"Al Shaikh","year":"2020","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-5276.21.06531-9","article-title":"Efficacy of Advanced Hybrid Closed Loop Systems for the Management of Type 1 Diabetes in Children","volume":"73","author":"Ferrito","year":"2021","journal-title":"Minerva Pediatr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0110","article-title":"Duration of Catheter Use in Patients With Diabetes Using Continuous Subcutaneous Insulin Infusion: A Review","volume":"20","author":"Bonato","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816662949","article-title":"Adhesives Used for Diabetes Medical Devices: A Neglected Risk With Serious Consequences","volume":"10","author":"Heinemann","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0089","article-title":"Perception and Possible Causes of Skin Problems to Insulin Pump and Glucose Sensor: Results From Pediatric Focus Groups","volume":"20","author":"Berg","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1394381","article-title":"Frequency of Dermatological Side Effects of Continuous Subcutaneous Insulin Infusion in Children and Adolescents With Type 1 Diabetes","volume":"123","author":"Binder","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820947072","article-title":"High Frequency of Dermatological Complications in Children and Adolescents With Type 1 Diabetes: A Web-Based Survey","volume":"15","author":"Lombardo","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/1932296819882425","article-title":"Five-Month Follow-Up Shows No Improvement in Dermatological Complications in Children With Type 1 Diabetes Using Continuous Glucose Monitoring Systems and Insulin Pumps","volume":"15","author":"Weng","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2174\/1573399817666210903153837","article-title":"Skin Involvement in Paediatric Patients With Type 1 Diabetes","author":"Passanisi","year":"2021","journal-title":"Curr Diabetes Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1824-7288-36-2","article-title":"Contact Dermatitis in Children","volume":"36","author":"Pigatto","year":"2010","journal-title":"Ital J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13120","article-title":"Allergic Contact Dermatitis Caused by Medical Devices for Diabetes Patients: A Review","volume":"79","author":"Herman","year":"2018","journal-title":"Contact Dermatitis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0007","article-title":"Skin Problems Due to Treatment With Technology are Associated With Increased Disease Burden Among Adults With Type 1 Diabetes","volume":"21","author":"Christensen","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1987","article-title":"New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes","volume":"32","author":"Mortensen","year":"2009","journal-title":"Diabetes Care"},{"key":"B20","article-title":"Contact Dermatitis","volume-title":"Statpearls [Internet]","author":"Litchman","year":"2021"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0080","article-title":"Preserving Skin Integrity With Chronic Device Use in Diabetes","volume":"20","author":"Messer","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15239","article-title":"British Association of Dermatologists\u2019 Guidelines for the Management of Contact Dermatitis 2017","volume":"176","author":"Johnston","year":"2017","journal-title":"Br J Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1040-0486(06)80006-2","article-title":"Practical Problems in the Use of Patch Testing in the Evaluation of Patients With Contact Dermatitis","volume":"2","author":"Nethercott","year":"1990","journal-title":"Curr Probl Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108089","article-title":"Allergic Contact Dermatitis in Pediatric Patients With Type 1 Diabetes: An Emerging Issue","volume":"162","author":"Lombardo","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13337","article-title":"Allergic Contact Dermatitis Caused by Glucose Sensors in Type 1 Diabetes Patients","volume":"81","author":"Hyry","year":"2019","journal-title":"Contact Dermatitis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12866","article-title":"Allergic Contact Dermatitis Caused by Isobornyl Acrylate in Freestyle\u00ae Libre, a Newly Introduced Glucose Sensor","volume":"77","author":"Herman","year":"2017","journal-title":"Contact Dermatitis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818762946","article-title":"Further Evidence of Severe Allergic Contact Dermatitis From Isobornyl Acrylate While Using a Continuous Glucose Monitoring System","volume":"12","author":"Kamann","year":"2018","journal-title":"J Diabetes Sci Technol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13017","article-title":"Isobornyl Acrylate Contained in the Insulin Patch Pump Omnipod as the Cause of Severe Allergic Contact Dermatitis","volume":"79","author":"Oppel","year":"2018","journal-title":"Contact Dermatitis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cod.12995","article-title":"Allergic Contact Dermatitis Caused by Isobornyl Acrylate in Omnipod, an Innovative Tubeless Insulin Pump","volume":"79","author":"Raison-Peyron","year":"2018","journal-title":"Contact Dermatitis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16981","article-title":"Continuous Glucose Monitoring Systems Give Contact Dermatitis in Children and Adults Despite Efforts of Providing Less A\u2019llergy- Prone\u2019 Devices: Investigation and Advice Hampered by Insufficient Material for Optimized Patch Test Investigations","volume":"35","author":"Svedman","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13012","article-title":"Allergic Contact Dermatitis and Diabetes Medical Devices: 2 Clinical Cases","volume":"79","author":"Passanisi","year":"2018","journal-title":"Contact Dermatitis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0236","article-title":"High Prevalence of Skin Reactions Among Pediatric Patients With Type 1 Diabetes Using New Technologies: The Alarming Role of Colophonium","volume":"22","author":"Lombardo","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1354","article-title":"Prevalence and Prevention of Contact Dermatitis Caused by Freestyle Libre: A Monocentric Experience","volume":"43","author":"Pyl","year":"2020","journal-title":"Diabetes Care"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13511","article-title":"Prevalence of Contact Dermatitis to Glucose Sensors in Pediatric Population and the Main Allergens Involved","volume":"83","author":"Vidal-Albareda","year":"2020","journal-title":"Contact Dermatitis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08875-0","article-title":"Contact Dermatitis: Classifications and Management","volume":"61","author":"Li","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaip.2015.02.009","article-title":"Contact Dermatitis: A Practice Parameter-Update 2015","volume":"3","author":"Fonacier","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/361746","article-title":"Noneczematous Contact Dermatitis","volume":"2013","author":"Bonamonte","year":"2013","journal-title":"ISRN Allergy"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2003.00072.x","article-title":"Evidence-Based Diagnosis in Patch Testing","volume":"48","author":"van der Valk","year":"2003","journal-title":"Contact Dermatitis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-019-01446-y","article-title":"\u00abOut of the Box\u00bb Solution for Skin Problems Due to Glucose-Monitoring Technology in Youth With Type 1 Diabetes: Real-Life Experience With Fluticasone Spray","volume":"57","author":"Paret","year":"2020","journal-title":"Acta Diabetol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028","article-title":"Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.846137\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T09:31:34Z","timestamp":1647336694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.846137\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":40,"alternative-id":["10.3389\/fendo.2022.846137"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.846137","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"article-number":"846137"}}